CLINICAL_TRIALS
trial_result
· 2021-11-16
Clinical Trial Update: A Safety and Immunogenicity Trial of IHV01 [Phase 1]
Summary
Phase 1 safety and immunogenicity trial of IHV01 completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: HIV Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-11-16